Intrexon News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

11.07.17	Oxitec Launching Friendly™ Aedes Project in Juiz de Fora, Brazil (PR Newswire)
06.07.17	Oxitec's Friendly™ Aedes Mosquito Receives Positive Evaluation for European Standard in relation to Human Health and the Environment (PR Newswire)
06.07.17	Oxitec's Friendly™ Aedes Mosquito Receives Positive Evaluation for European Standard in relation to Human Health and the Environment (PR Newswire)
29.06.17	Intrexon Appoints Helen Sabzevari, Ph.D., Senior Vice President, Human Therapeutics and Head of Research and Development of Precigen (PR Newswire)
16.06.17	Intrexon Integrates Leading Adenoviral Gene Delivery Technology with Completion of GenVec Acquisition (PR Newswire)
13.06.17	AquaBounty Acquires Fish Farming Facility in Indiana (PR Newswire)
13.06.17	Intrexon and Johnson Matthey Collaborate on Fermentative Production of Peptide-based Active Pharmaceutical Ingredients (PR Newswire)
07.06.17	Wegmans, Publix Super Markets, Amazon, Tesla and USAA Draw Top Social Responsibility Scores in Harris Poll (PR Newswire)
31.05.17	Intrexon's Head of Environment Sector Joins Brazil Investment Forum to Discuss Importance of Vector Control and Economic Impact of Vector-borne Diseases (PR Newswire)
31.05.17	Intrexon's Head of Environment Sector Joins Brazil Investment Forum to Discuss Importance of Vector Control and Economic Impact of Vector-borne Diseases (PR Newswire)
18.05.17	Intrexon Appoints Dr. Mark Carnegie-Brown as CEO of Oxitec (PR Newswire)
15.05.17	Intrexon to Present at the Bank of America Merrill Lynch 2017 Healthcare Conference (PR Newswire)
12.05.17	Biotech Stocks on Investors' Radar -- Progenics Pharma, Dynavax Technologies, Intrexon, and Heat Biologics (PR Newswire)
12.05.17	Gainers & Losers Of May 11: SGMO, RNN, XON, MNKD, NVCN... (RTTNews)
10.05.17	Intrexon Announces First Quarter 2017 Financial Results (PR Newswire)
10.05.17	Intrexon and Darling to Build Commercial-scale Production of Insect-Based Advanced Feed Ingredients (PR Newswire)
09.05.17	Kilroy Realty And Nautilus Solar Energy Announce A 5MW Commercial Solar Portfolio Development In California (PR Newswire)
09.05.17	Huvepharma to Utilize Intrexon's Proprietary Fungal Expression Platform to Produce Key Animal Feed Enzyme (PR Newswire)
03.05.17	Intrexon to Announce First Quarter 2017 Financial Results on May 10th (PR Newswire)
27.04.17	Intrexon Appoints Vinita Gupta, Leading Pharma Executive, to its Board of Directors (PR Newswire)
19.04.17	Synthetic Biologics Reports Preclinical Data Demonstrating SYN-005 Provides Protection from Pertussis in Neonatal Animal Study (PR Newswire)
10.04.17	The Municipality of Santiago de Cali, Colombia, and Oxitec Ltd. Announce Memorandum to Deploy Friendly™ Aedes (PR Newswire)
10.04.17	The Municipality of Santiago de Cali, Colombia, and Oxitec Ltd. Announce Memorandum to Deploy Friendly™ Aedes (PR Newswire)
30.03.17	Oxitec's Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project (PR Newswire)
30.03.17	Oxitec's Friendly™ Aedes Achieves 81% Suppression of Wild Aedes aegypti in CECAP/Eldorado, Piracicaba, in Second Year of Project (PR Newswire)
30.03.17	Research Reports Coverage on Biotech Stocks -- Agenus, Intrexon, Progenics Pharma, and Concordia (PR Newswire)
17.03.17	Jorge Espanha Appointed General Manager of Oxitec do Brasil (PR Newswire)
17.03.17	Jorge Espanha Appointed General Manager of Oxitec do Brasil (PR Newswire)
16.03.17	AquaBounty Technologies, Inc. Results for the year ended December 31, 2016 (PR Newswire)
10.03.17	Intrexon Creates Precigen, Inc. and Accelerates Strategic Review of Structural Options Related to Health Assets (PR Newswire)
06.03.17	Andy Bass to Lead Biological & Popular Culture, Intrexon's Consumer Sector (PR Newswire)
22.02.17	Intrexon to Announce Fourth Quarter and Full Year 2016 Financial Results on March 1st (PR Newswire)
09.02.17	Technical Reports on Biotech Stocks -- Progenics Pharma, Intrexon, Synthetics Biologics, and 22nd Century (PR Newswire)
24.01.17	Intrexon to Acquire GenVec to Expand Industry-Leading Gene Delivery Platform (PR Newswire)
23.01.17	Oxitec and GBIT Announce Launch of Friendly™ Aedes Project in India (PR Newswire)
23.01.17	Oxitec and GBIT Announce Launch of Friendly™ Aedes Project in India (PR Newswire)
19.01.17	AquaBounty Announces Completion of NASDAQ Listing and Equity Subscription from Intrexon (PR Newswire)
12.01.17	Intrexon Announces "When-Issued" Trading of AquaBounty Technologies In Connection With Special Stock Dividend of Shares (PR Newswire)
10.01.17	ZIOPHARM and Intrexon Announce Cooperative Research and Development Agreement with the National Cancer Institute Utilizing Sleeping Beauty System to Generate T cells Targeting Neoantigens (PR Newswire)
29.12.16	Intrexon Announces a Special Stock Dividend of Shares of AquaBounty Technologies (PR Newswire)
22.12.16	Biotech Stocks on Investors' Radar -- Peregrine Pharma, Intrexon, Rexahn Pharma, and Tesaro (PR Newswire)
13.12.16	Intrexon Advances ActoBiotics™ Platform to Development Phase for Biological Crop Protection (PR Newswire)
13.12.16	Synthetic Biologics Announces Granting of U.S. Composition of Matter Patent for SYN-005, Designed for the Treatment and Prevention of Pertussis (Whooping Cough) (PR Newswire)
12.12.16	Oxitec's Medfly Ready for Open Field Trials (PR Newswire)
12.12.16	Oxitec's Medfly Ready for Open Field Trials (PR Newswire)
30.11.16	Oxitec Announces Friendly™ Aedes Project is Supported By 92.8% of Piracicaba’s Population (PR Newswire)
21.11.16	Board of Florida Keys Mosquito Control District Approves Investigational Agreement for Effectiveness Trial of Oxitec's Friendly™ Mosquitoes in Monroe County, Florida (PR Newswire)
21.11.16	Board of Florida Keys Mosquito Control District Approves Investigational Agreement for Effectiveness Trial of Oxitec's Friendly™ Mosquitoes in Monroe County, Florida (PR Newswire)
15.04.16	D-Day Awaits CHMA, APHB Abandons XON Collaboration, More On The Way For Opdivo (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’291.00	1.77 %	K V
ABB	50.06	1.17 %	K V
Holcim	89.02	1.07 %	K V
Roche Hldg G	266.70	0.87 %	K V
UBS Group	29.64	0.68 %	K V
Givaudan	3’884.00	-0.49 %	K V
Geberit	509.00	-0.90 %	K V
Zurich Insur Gr	546.80	-0.91 %	K V
Logitech Intl	78.88	-1.25 %	K V
Sonova Hldg	294.20	-1.28 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Intrexon Corp

Aktien Top/Flop

Meistgelesene Nachrichten